Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Inventory (2020 - 2025)

Historic Inventory for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$1.5 billion.

  • Universe Pharmaceuticals' Inventory fell 10015.39% to -$1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year decrease of 10015.39%. This contributed to the annual value of -$1.5 billion for FY2025, which is 10015.39% down from last year.
  • Per Universe Pharmaceuticals' latest filing, its Inventory stood at -$1.5 billion for Q3 2025, which was down 10015.39% from $978.2 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Inventory peaked at $978.2 billion during Q3 2024, and registered a low of -$1.5 billion during Q3 2025.
  • Its 5-year average for Inventory is $122.1 billion, with a median of $288339.5 in 2023.
  • As far as peak fluctuations go, Universe Pharmaceuticals' Inventory tumbled by 780527.64% in 2023, and later surged by 57545937.79% in 2024.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Inventory stood at $2.7 million in 2021, then dropped by 19.42% to $2.2 million in 2022, then tumbled by 7805.28% to -$170.0 million in 2023, then skyrocketed by 575459.38% to $978.2 billion in 2024, then crashed by 100.15% to -$1.5 billion in 2025.
  • Its Inventory stands at -$1.5 billion for Q3 2025, versus $978.2 billion for Q3 2024 and $368960.0 for Q1 2024.